Title:Validity of Oxygen-Ozone Therapy as Integrated Medication Form in Chronic Inflammatory Diseases
Volume: 15
Issue: 2
Author(s): Velio Bocci, Iacopo Zanardia, Giuseppe Valacchi, Emma Borrelli and Valter Travagli
Affiliation:
Keywords:
Age-related macular degeneration, dry form, chronic obstructive pulmonary disease, integrative medicine, oxygenozone
therapy, peripheral arterial occlusive disease, reactive oxygen species, stroke.
Abstract: The state-of-the-art of oxygen-ozone therapy is now clarified and all the mechanisms of action of medical
ozone are within classical biochemistry and molecular biology. The outcomes of standard treatments in peripheral
arterial occlusive disease (PAOD) and dry-form of age-related macular degeneration (AMD) have been compared with
the documented therapeutic results achieved with ozonated autohemotherapy (O-AHT). On the other hand, the clinical
data of O-AHT on stroke remain indicative. As the cost of O-AHT is almost irrelevant, its application in all
public hospitals, especially those of poor Countries, would allow two advantages: the first is for the patient, who will
improve her/his conditions, and the second is for Health Authorities burdened with increasing costs. The aim of this paper
is to report to clinical scientists that O-AHT is a scientific-based therapeutic approach without side effects. The integration
of O-AHT with effective approved drugs is likely to yield the best clinical results in several chronic inflammatory
diseases.
